Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States…
$107.15+1.28%
报价 2026-11-13
市值
$61.61B
EV
$45.4B
PE (TTM)
44.5x
预期 PE (FY2026)
35.5x
52 周区间距高点 0.0%
$75.87$107.15
筛选结果
pipeline · 2026-11-13Keep✗ 高增长✗ Cheap✓ GARP
GARP Pool: growth 10-30%, MC/GP <= 11
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 2.94 → 3.40(1.2x) | 31.5 |
| FY+32028-12 | 1.2x | 2.94 → 3.84(1.3x) | 27.9 |
毛利率 78% · TTM 收入 $6675M · 基数 EPS 2.94(调整后)
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| EWEdwards Lifesciences Corporation | $61.61B | +1.3% | +12.7% | 78.1% | 44.5x | 32.6x | 43.3x | GARP |
| CAHCardinal Health, Inc. | $64.97B | +1.1% | +4.1% | 4.3% | 31.6x | 16.9x | 11.9x | |
| ARGXargenx SE | $60.37B | -2.2% | – | 89.9% | 38.2x | 39.0x | 58.5x | |
| BDXBecton, Dickinson and Company | $59.39B | +1.1% | +2.4% | 45.8% | 25.3x | 14.7x | 21.1x | |
| AAgilent Technologies, Inc. | $49.05B | +0.5% | +6.5% | 26% | 27.1x | 23.0x | 34.2x | |
| VEEVVeeva Systems Inc. | $48.82B | -0.3% | +16.5% | 75% | 48.9x | 36.6x | 29.9x | |
| HLNHaleon plc | $40.25B | +0.9% | – | 61.8% | 21.8x | 14.3x | – | |
| ALCAlcon Inc. | $35.61B | +3.2% | – | 54.8% | 37.0x | 21.0x | – | |
| DXCMDexCom, Inc. | $31.08B | +2.4% | +12.4% | 63.4% | 34.4x | 21.8x | 23.9x | GARP |
| 同行中位数 | – | – | +6.5% | 58.3% | 33.0x | 21.4x | 26.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。